Feasibility of Using a Wearable Biosensor Device in Patients at Risk for Alzheimer's Disease Dementia.

ABSTRACT:

Background

Alzheimer's disease (AD) is the most common and most costly chronic neurodegenerative disease globally. AD develops over an extended period prior to cognitive symptoms, leaving a "window of opportunity" for targeted risk-reduction interventions. Further, this pre-dementia phase includes early physiological changes in sleep and autonomic regulation, for which wearable biosensor devices may offer a convenient and cost-effective method to assess AD-risk.

Methods

Patients with a family history of AD and no or minimal cognitive complaints were recruited from the Alzheimer's Prevention Clinic at Weill Cornell Medicine and New York-Presbyterian. Of the 40 consecutive patients screened, 34 (85%) agreed to wear a wearable biosensor device (WHOOP). One subject (2.5%) lost t

SUBMITTER: Saif N 

PROVIDER: S-EPMC8202529 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature